The EU Commission invites comments from all interested parties on commitments offered by pharmaceutical company to address the Commission’s concerns over excessive pricing (Aspen)

Aspen: Quick Fix But Missed Opportunity* What are commitments? The recent effort by the Commission to settle the Aspen case suggests that commitment decisions are the preferred route to settle complex excessive pricing cases at EU-level. Previous commitment cases where high prices have been at issue include Rambus, Standard & Poor’s and Gazprom. The EU rules allow the Commission to make legally binding Aspen’s promise to amend its business practice and lower drug prices. In return, the Commission closes its investigations without imposing a fine or finding an infringement of the EU competition rules. All going well, commitment decisions are a fast and flexible competition tool. That said, EU commitment decisions are without prejudice to the powers of national courts to apply

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Bertold Bar-Bouyssière, Alina Lacatus, Jacob Borum, Darach Connolly, The EU Commission invites comments from all interested parties on commitments offered by pharmaceutical company to address the Commission’s concerns over excessive pricing (Aspen), 14 July 2020, e-Competitions July 2020, Art. N° 97399

Visites 61

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues